论文部分内容阅读
输血治疗是临床治疗中的重要措施。作为一种支持性与代偿性的治疗方法,输血在很多情况下是抢救危重患者生命行之有效的手段。输血包括输全血和成分血,成分血包括红细胞、血小板、血浆等,临床中要根据患者需求做出选择。我们知道,输血治疗是存在风险的,即使血源按国家规定采用合格试剂进行了严格检测,但受科技水平的限制及不可预知因素的影响,输血风险有时仍难以避免。这里主要是两个方面的问题:一是输血不良反应的发生;二是输血相关疾病的传播。因此,在输血前医生需按照《临床输血技术规范》向患者或其家属告知输血目的、可能发生的输血反应和经血传播疾
Blood transfusion therapy is an important measure in clinical treatment. As a supportive and compensatory treatment method, blood transfusion is, in many cases, an effective means to save the lives of critically ill patients. Blood transfusion includes transfusion of whole blood and blood components. Blood components include red blood cells, platelets, and plasma. Clinical selection is based on patient needs. We know that there is a risk of transfusion therapy. Even if the blood source is rigorously tested using qualified reagents according to national regulations, transfusion risk is sometimes difficult to avoid due to scientific and technological limitations and unpredictable factors. Here are two main issues: First, the occurrence of adverse reactions to blood transfusion; Second, the transmission of blood transfusion-related diseases. Therefore, prior to transfusion, doctors should inform patients or their families of the purpose of blood transfusion, possible transfusion reactions, and menstrual diseases, in accordance with the Technical Specifications for Clinical Blood Transfusion.